Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases - Top-Institutions - MDSpire

Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases

  • By

  • Sukwoo Hong

  • Hirokazu Takami

  • Motoyuki Umekawa

  • Yuki Shinya

  • Hirotaka Hasegawa

  • Mariko Kawashima

  • Yosuke Kitagawa

  • Masashi Nomura

  • Shunsaku Takayanagi

  • Shota Tanaka

  • Nobuhito Saito

  • October 15, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Immuno-oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Hematology-Oncology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Radiation Oncology
    • Neuro-oncology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Immunology

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Cancer Immunology

Original Source(s)

Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases

  • by Sukwoo Hong, Hirokazu Takami, Motoyuki Umekawa, Yuki Shinya, Hirotaka Hasegawa, Mariko Kawashima, Yosuke Kitagawa, Masashi Nomura, Shunsaku Takayanagi, Shota Tanaka, Nobuhito Saito

  • October 15, 2025

Related Content

Papillary thyroid carcinoma with brain and lung metastases: a case report

A pharmacodynamic study of rapid lactate metabolic modulation by intravenous L-arginine in brain metastases

Challenges and Utilization of Immune Checkpoint Inhibitors in the Treatment of Lung Cancer